Evolent Health, Inc.

NYSE:EVH

Medical - Healthcare Information Services

Healthcare
$3.93 -6.00%

-$0.28 today

Market cap
$442.05M
Beta
0.83
P/E (TTM)
-1.0
EPS (TTM)
-$4.44
52W Low $2.10High $12.07

Volume 3.10M

Average 2.78M

EVH Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Evolent Health, Inc.NYSE: EVH

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 12.5%

Gross margin was 12.5% in Q1 FY2026, down 8.7 pp from a year earlier. On a trailing-twelve-month basis it was 14.1%, down 1.1 pp year over year. Over 3 fiscal years it narrowed by 8.3 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
12.5%+1.3 pp QoQ
Last fiscal yearDec 2025
15.1%+0.8 pp YoY
LTMMar 2026
14.1%-1.1 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-8.7 pp——
1 year+0.8 pp——
3 years-8.3 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
15.1%
Year-over-year change
+0.8pp

Gross Margin vs competitors

How EVH compares with its peers on the latest reported figures

  • EVH's LTM Mar 2026 gross margin of 14.1% is the 8th highest of the 9 companies compared; the peer median is 57.0%.
  • Its year-over-year change of -1.1 pp is the 4th highest of 9, against a peer median of -1.3 pp.
  • Over three fiscal years its change of -8.3 pp compares with a peer median of -2.7 pp.
EVH Competitors Peer median
Gross Margin for EVH and competitors
Company Period LTM level YoY 3-year change
KURAKura Oncology, Inc.LTM Mar 202694.7% -5.0 pp—
MGTXMeiraGTx Holdings plcLTM Mar 202691.6% +64.6 pp-6.0 pp
MYGNMyriad Genetics, Inc.LTM Mar 202670.0% -0.0 pp-0.3 pp
HSTMHealthStream, Inc.LTM Mar 202664.9% -1.3 pp-1.1 pp
BFLYButterfly Network, Inc.LTM Mar 202649.2% -11.4 pp-6.9 pp
NUTXNutex Health, Inc.LTM Mar 202647.5% -1.3 pp+43.7 pp
AMNAMN Healthcare Services, Inc.LTM Mar 202627.6% -1.0 pp-4.4 pp
EVHEvolent Health, Inc.LTM Mar 202614.1% -1.1 pp-8.3 pp
PSNLPersonalis, Inc.LTM Mar 202613.7% -19.6 pp—
REPLReplimune Group, Inc.FY2025— ——
AVBPArriVent BioPharma, Inc. Common StockFY2025— ——
Peer median (excluding EVH) 57.0%-1.3 pp-2.7 pp

Competitors are the stored peer set for EVH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue907.96M1.35B1.96B2.55B1.88B
Cost of Revenue657.55M1.04B1.5B2.19B1.59B
Gross Profit250.41M316.58M460.47M367.35M284.03M
Gross Margin27.6%23.4%23.4%14.4%15.1%
Research & Development027M000
Selling, General & Admin219.5M269.27M358.11M263.05M288.47M
Operating Expenses292.82M312.94M531.68M407.84M288.47M
Depreciation & Amortization60.04M90.25M123.42M123.17M115.85M
EBITDA55.66M43.75M(24.79M)84.85M(361.31M)
EBITDA Margin6.1%3.2%-1.3%3.3%-19.3%
Operating Income(42.41M)3.64M(71.21M)(40.49M)(4.44M)
Operating Margin-4.7%0.3%-3.6%-1.6%-0.2%
Interest Income407K1.37M5.26M5.54M4.19M
Interest Expense25.43M15.57M54.21M24.72M57.47M
Other Income / Expenses12.61M(65.72M)(131.19M)(22.55M)(530.2M)
Income Before Tax(29.8M)(62.08M)(202.41M)(63.04M)(534.64M)
Pre-Tax Margin-3.3%-4.6%-10.3%-2.5%-28.5%
Income Tax Expense483K(43.38M)(89.37M)(1.41M)(126K)
Net Income(37.6M)(19.16M)(113.04M)(61.62M)(534.51M)
Net Margin-4.1%-1.4%-5.8%-2.4%-28.5%
EPS (Basic)(0.36)(0.20)(1.28)(0.81)(5.07)
EPS (Diluted)(0.36)(0.20)(1.28)(0.81)(5.07)
Weighted Avg Shares86.07M93.7M111.25M114.68M114.21M
Weighted Avg Shares (Diluted)86.07M93.7M111.25M114.68M114.21M

Evolent Health, Inc.

NYSE:EVH

Intrinsic Alpha fair value

Locked

Current Price

$3.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.